Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.2147/MDER.S65492 http://scihub22266oqcxt.onion/10.2147/MDER.S65492 C5015878!5015878!27621674     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Med+Devices+(Auckl) 2016 ; 9 (ä): 309-16 Nephropedia Template TP {{tp|p=27621674|t=2016. Percutaneous left atrial appendage closure devices: safety, efficacy, and clinical utility |pdf=|usr=}}{{27621674}} gab.com Text Percutaneous left atrial appendage closure devices: safety, efficacy, and clinical utility JO: Med Devices (Auckl) http://www.kidney.de/pget.php?&tw=1&pmid=27621674 #FOAvip Atrial fibrillation (AF) is the most common arrhythmia treated in the clinical practice. One of the major complications of AF is a thromboembolic cerebral ischemic event. Up to 20% of all strokes are caused by AF. Thromboembolic cerebral ischemic event in patients with AF occurs due to atrial thrombi, mainly from the left atrial appendage (LAA). Prevention of clot formation with antiplatelet agents and especially oral anticoagulants (vitamin K antagonists or newer oral anticoagulants) has been shown to be effective in reducing the stroke risk in patients with AF but has several drawbacks with (major) bleedings as the most important disadvantage. Therefore, physical elimination of the LAA, which excludes the site of clot formation by surgical or percutaneous techniques, might be a good alternative. In this review, we discuss the safety, efficacy, and clinical utility of the Watchman? LAA closure device. Twit Text FOAVip Percutaneous left atrial appendage closure devices: safety, efficacy, and clinical utility ????Med Devices (Auckl) http://www.kidney.de/pget.php?&tw=1&pmid=27621674 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=27621674 #FOAvip English Wikipedia <ref>{{Cite pmid|27621674}}</ref> Percutaneous left atrial appendage closure devices: safety, efficacy, and clinical utility #MMPMID27621674 Swaans MJ; Wintgens LI; Alipour A; Rensing BJ; Boersma LV Med Devices (Auckl) 2016[]; 9 (ä): 309-16 PMID27621674show ga Atrial fibrillation (AF) is the most common arrhythmia treated in the clinical practice. One of the major complications of AF is a thromboembolic cerebral ischemic event. Up to 20% of all strokes are caused by AF. Thromboembolic cerebral ischemic event in patients with AF occurs due to atrial thrombi, mainly from the left atrial appendage (LAA). Prevention of clot formation with antiplatelet agents and especially oral anticoagulants (vitamin K antagonists or newer oral anticoagulants) has been shown to be effective in reducing the stroke risk in patients with AF but has several drawbacks with (major) bleedings as the most important disadvantage. Therefore, physical elimination of the LAA, which excludes the site of clot formation by surgical or percutaneous techniques, might be a good alternative. In this review, we discuss the safety, efficacy, and clinical utility of the Watchman? LAA closure device. äPercutaneous left atrial appendage closure devices: safety, efficacy, (epmc).pdf DeepDyve Pubget Overpricing